Mahathir Bayena

Urban Edge Properties (NYSE:UE) is rewarding shareholders after a year of aggressive leasing and portfolio refinement, announcing an 11% increase in its quarterly dividend alongside its fourth-quarter 2025 results.

Cellebrite (NASDAQ:CLBT) delivered record fourth-quarter and full-year 2025 results, signaling a successful transition from a hardware-centric forensics provider to a high-margin, AI-powered software platform.

Gemini’s decision to exit the United Kingdom, European Union and Australia to focus on the United States and Singapore has intensified scrutiny over the UK’s ambition to become a global crypto hub.

Bitcoin’s drop to around $60,000 may represent the halfway stage of the current bear market rather than a definitive cycle bottom, according to Kaiko Research.

Ethereum is trading near $2,000 as prolonged weakness pushes key on-chain valuation metrics into ranges historically associated with major market bottoms.

Stablecoin-focused blockchain startup Tempo has added Farcaster co-founders Dan Romero and Varun Srinivasan after infrastructure firm Neynar acquired the Farcaster social protocol in January.

Goldman Sachs has disclosed a $1.1 billion position in Bitcoin exchange-traded funds, lifting its total crypto-related exposure to about $2.36 billion, according to regulatory filings.

Humana (NYSE:HUM) issued a sobering outlook for 2026, projecting that a significant drop in government bonus payments will weigh on its bottom line even as the insurer sees a massive rebound in customer acquisition.

Madrigal Pharmaceuticals (NASDAQ:MDGL) is doubling down on its dominance of the liver-disease market, announcing an expansive partnership with Ribo to develop next-generation gene-silencing therapies.